- Review
Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
- Xiao-Yan Yang,
- Yuan-Fei Lu,
- Jian-Xia Xu,
- Yong-Zhong Du and
- Ri-Sheng Yu
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis and low survival rate. Due to its inconspicuous symptoms, PDAC is difficult to diagnose early. Most patients are diagnosed in the middle and late sta...

